출판 : MarketsandMarkets（마켓츠앤드마켓츠）출판년월 : 2022년04월
메타게놈 시퀀싱 시장 : 제품 및 서비스(시약, 소모품, 장비), 워크플로(샘플 준비, 시퀀싱), 기술(16S rRNA, 샷건, 전체 게놈), 용도(창약, 진단) – 2027년까지의 세계 예측
Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic) – Global Forecast to 2027
| 페이지수 | 239 |
| 도표수 | 255 |
| 구성 | 영문조사보고서 |
| 가격 |
The metagenomic sequencing market is expected to reach USD 4.3 billion by 2027 from USD 1.9 billion in 2022, at a CAGR of 18.4% during the forecast period.
메타게놈 시퀀싱 시장은 예측 기간 동안 18.4%의 CAGR로 2022년 19억 달러에서 2027년 43억 달러에 이를 것으로 예상됩니다.
Growth in the metagenomic sequencing market is mainly driven by continuous technological innovations in NGS platforms, increasing initiatives and funding from government & private bodies for large-scale sequencing projects, declining costs of genome sequencing, and the significant applications of metagenomics in various fields.
성장은 주로 NGS 플랫폼의 지속적인 기술 혁신, 대규모 시퀀싱 프로젝트에 대한 정부 및 민간 기관의 이니셔티브 및 자금 조달 증가, 게놈 시퀀싱 비용 감소, 다양한 분야에서 메타게놈의 중요한 응용에 의해 주도됩니다.
“By technology segment, the shotgun metagenomic sequencing segment accounted for the fastest-growing segment of the metagenomic sequencing market”
Based on technology, the metagenomic sequencing market is segmented into 16S rRNA sequencing, shotgun metagenomic sequencing, whole-genome sequencing & de novo assembly, and metatranscriptomics. The shotgun metagenomic sequencing segment is estimated to grow at the highest CAGR during the forecast period. This can be attributed to its advantages over other techniques, the growing adoption of shotgun metagenomic sequencing among researchers and healthcare professionals, and the increasing number of metagenomic sequencing-based research activities.
“By workflow segment, the sample processing & library preparation segment accounted for the largest share of the metagenomic sequencing market”
Based on workflow, the market has been segmented into sample processing & library preparation, sequencing, and data processing & analysis. The sample processing & library preparation segment accounted for the largest share of the metagenomic sequencing market in 2021. The large share of this segment can be attributed to the growing number of metagenome sequencing research projects being conducted, the availability of technologically advanced and robust sample processing and library preparation assay kits, and the demand for efficient library preparation products.
“Asia Pacific: The fastest-growing region in the metagenomic sequencing market.”
The market in the Asia Pacific is expected to register the highest growth rate during the forecast period, primarily due to the increasing financial support from public as well as private agencies, the increasing number of NGS-based research projects, increasing awareness about precision medicine, and the rising prevalence of chronic diseases.
“North America: the largest share of the metagenomic sequencing market”
North America accounted for the largest share of the metagenomic sequencing market in 2021. Factors such as the increasing applications of metagenomics in diagnostics and genomics research, the availability of research funding, and the development of NGS data analysis solutions are driving the growth of the metagenomic sequencing market in North America.
Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
• By Respondent– Supply Side- 70%, Demand Side-30%
• By Designation— CXOs and Directors- 30%, Executives – 25%, Mangers – 45%
• By Region— North America – 40%, Europe – 25%, APAC – 20%, LATAM- 10% , MEA- 5%
Prominent players in the metagenomic sequencing market include Illumina Inc. (US), Thermo Fisher Scientific lnc. (US), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (US), Oxford Nanopore Technologies (UK), Pacific Biosciences (US), BGI group (China), Psomagen Inc. (South Korea), Eurofins Scientific (Luxembourg), Zymo Research Corporation (US), Tecan Trading AG (Switzerland), Integragen SA (France), Microsynth AG (Switzerland), DNAStar Inc. (US), Brooks Automation, Inc. (US), and Novogene Co., Ltd. (China), Osmosis, INC. (US), Genexa AG. (Switzerland), Varigen Biosciences (US), Veritas Genetics (US), SinGENE (Singapore), Intact Genomics, Inc., Metagenomi (US), Computomics (Germany), and IDbyDNA Inc. (US).
Research Coverage:
The report segments the metagenomic sequencing market based on region (the Asia Pacific, Europe, North America, Latin America, and the Middle East & Africa), by Workflow (Sample Preparation, Sequencing, Data Processing and Analysis), by Product and Services (Instruments, Reagents and Consumables, Analysis and Data Interpretation Solutions, Metagenomic Sequencing Services), by Technology (Shotgun Metagenomic Sequencing, 16s Rrna Sequencing, Whole-Genome Sequencing and De Novo Assembly, Metatranscriptomics), by Application (Ecological and Environmental Metagenomics, Clinical Diagnostic Metagenomics, Drug Discovery Metagenomics, Soil Microbiome, Industrial Applications [Energ, Bioremediation, Other Industrial Application], Veterinary Metagenomics, Other Metagenomic Applications). The report also provides a comprehensive review of market drivers, restraints opportunities, challenges and trends in the metagenomic sequencing market.
Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the metagenomic sequencing market and provides them information on key market drivers, restraints, challenges, and opportunities.
목차
TABLE OF CONTENTS
1 INTRODUCTION (Page No. – 30)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 METAGENOMIC SEQUENCING MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. – 35)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
FIGURE 4 METAGENOMIC SEQUENCING MARKET: BREAKDOWN OF PRIMARIES
2.1.2.1 Key industry insights
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2021
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP (SUPPLY SIDE) – COLLECTIVE REVENUE OF ALL METAGENOMIC SEQUENCING PRODUCTS & SERVICES
FIGURE 7 METAGENOMIC SEQUENCING MARKET: CAGR PROJECTIONS, 2022–2027
FIGURE 8 METAGENOMIC SEQUENCING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH LIMITATIONS
2.5 GROWTH RATE ASSUMPTIONS
2.6 RISK ANALYSIS
3 EXECUTIVE SUMMARY (Page No. – 46)
FIGURE 10 METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 11 METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021
FIGURE 12 METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 13 METAGENOMIC SEQUENCING MARKET SHARE, BY TECHNOLOGY, 2021
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF THE METAGENOMIC SEQUENCING MARKET
4 PREMIUM INSIGHTS (Page No. – 51)
4.1 METAGENOMIC SEQUENCING MARKET OVERVIEW
FIGURE 15 TECHNOLOGICAL INNOVATIONS IN NGS PLATFORMS—A KEY FACTOR DRIVING GROWTH IN THE METAGENOMIC SEQUENCING MARKET
4.2 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY & COUNTRY (2021)
FIGURE 16 16S RRNA SEQUENCING TECHNOLOGY ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021
4.3 METAGENOMIC SEQUENCING MARKET SHARE FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021
FIGURE 17 ENERGY APPLICATION SEGMENT DOMINATED THE MARKET IN 2021
5 MARKET OVERVIEW (Page No. – 54)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 METAGENOMIC SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Continuous technological innovations in NGS platforms
5.2.1.1.1 iSeq 100 System
5.2.1.1.2 Ion GeneStudio S5
5.2.1.2 Initiatives and funding from government & private bodies for large-scale sequencing projects
TABLE 1 GLOBAL SEQUENCING INITIATIVES
5.2.1.3 Declining costs of genome sequencing
FIGURE 19 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–2020
5.2.1.4 Significant applications of metagenomics in various fields
5.2.2 RESTRAINTS
5.2.2.1 End-user budget constraints in developing countries
5.2.3 OPPORTUNITIES
5.2.3.1 NGS data analysis using big data
FIGURE 20 DATA PRODUCTION DURING HUMAN WHOLE-GENOME SEQUENCING, 2001–2019
5.2.4 CHALLENGES
5.2.4.1 Challenges associated with metagenomic NGS
5.3 IMPACT OF COVID-19 ON THE METAGENOMIC SEQUENCING MARKET
5.4 PORTER’S FIVE FORCES ANALYSIS
TABLE 2 METAGENOMIC SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF SUPPLIERS
5.4.4 BARGAINING POWER OF BUYERS
5.4.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
5.5 VALUE CHAIN ANALYSIS
FIGURE 21 VALUE CHAIN ANALYSIS OF THE METAGENOMIC SEQUENCING MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE
FIGURE 22 VALUE CHAIN: METAGENOMIC SEQUENCING ANALYSIS WORKFLOW —MAXIMUM VALUE IS ADDED DURING THE SEQUENCING AND ANALYSIS PHASES
5.6 ECOSYSTEM ANALYSIS
FIGURE 23 ECOSYSTEM ANALYSIS: METAGENOMIC SEQUENCING MARKET
TABLE 3 SUPPLY CHAIN ECOSYSTEM
5.7 PATENT ANALYSIS
5.7.1 TOP 10 GRANTED PATENT OWNERS IN THE LAST 20 YEARS
5.7.2 TOP 10 PLAYERS WITH THE HIGHEST NO. OF PATENT APPLICATIONS
5.7.3 LIST OF RECENT PATENTS
5.8 SUPPLY CHAIN ANALYSIS
FIGURE 24 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY FOR PROMINENT COMPANIES
5.9 REGULATORY ANALYSIS
5.9.1 NORTH AMERICA
5.9.1.1 US
TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.9.1.2 Canada
5.9.2 EUROPE
5.9.3 ASIA PACIFIC
5.9.3.1 China
TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.9.3.2 Japan
5.9.3.3 India
5.9.4 LATIN AMERICA
5.9.5 MIDDLE EAST
5.10 PRICING ANALYSIS
TABLE 7 AVERAGE SELLING PRICE OF NGS SYSTEMS (2020)
5.11 RANGES/SCENARIOS
FIGURE 25 DEPENDING ON HOW THE UNCERTAINTIES UNFOLD, WE SEE A SPECTRUM OF SCENARIOS FOR THE METAGENOMIC SEQUENCING MARKET
5.12 TRADE ANALYSIS
5.12.1 TRADE ANALYSIS FOR METAGENOMIC SEQUENCING MARKET
TABLE 8 IMPORT DATA FOR HS CODE 902780, BY COUNTRY, 2016-2020 (USD THOUSAND)
TABLE 9 EXPORT DATA FOR HS CODE 902780, BY COUNTRY, 2016-2020 (USD THOUSAND)
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.14 KEY CONFERENCES & EVENTS, 2022
TABLE 10 METAGENOMIC SEQUENCING MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
TABLE 11 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP THREE APPLICATIONS (%)
TABLE 12 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
6 METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE (Page No. – 79)
6.1 INTRODUCTION
TABLE 13 METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
6.2 REAGENTS & CONSUMABLES
6.2.1 RISING ADOPTION OF METAGENOMIC SEQUENCING IS DRIVING THE USE OF REAGENTS & CONSUMABLES
TABLE 14 METAGENOMIC SEQUENCING REAGENTS & CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 15 NORTH AMERICA: METAGENOMIC SEQUENCING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 16 EUROPE: METAGENOMIC SEQUENCING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 17 APAC: METAGENOMIC SEQUENCING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 INSTRUMENTS
6.3.1 LAUNCH OF ADVANCED NGS PLATFORMS WILL SUPPORT THE GROWTH OF THIS SEGMENT
TABLE 18 METAGENOMIC SEQUENCING INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 19 NORTH AMERICA: METAGENOMIC SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 20 EUROPE: METAGENOMIC SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 21 APAC: METAGENOMIC SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 SERVICES
6.4.1 TIME AND COST-EFFECTIVENESS OF OUTSOURCING NGS PROJECTS HAS DRIVEN THE DEMAND FOR SERVICES
TABLE 22 METAGENOMIC SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 23 NORTH AMERICA: METAGENOMIC SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 24 EUROPE: METAGENOMIC SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 25 APAC: METAGENOMIC SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.5 ANALYSIS & DATA INTERPRETATION SOLUTIONS
6.5.1 LIMITED TECHNICAL KNOWLEDGE OF ADVANCED ANALYSIS SOLUTIONS AMONG END USERS TO HAMPER MARKET GROWTH
TABLE 26 METAGENOMIC SEQUENCING ANALYSIS & DATA INTERPRETATION SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 27 NORTH AMERICA: METAGENOMIC SEQUENCING ANALYSIS & DATA INTERPRETATION SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 28 EUROPE: METAGENOMIC SEQUENCING ANALYSIS & DATA INTERPRETATION SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 29 APAC: METAGENOMIC SEQUENCING ANALYSIS & DATA INTERPRETATION SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 METAGENOMIC SEQUENCING MARKET, BY WORKFLOW (Page No. – 88)
7.1 INTRODUCTION
TABLE 30 METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)
7.2 SAMPLE PROCESSING & LIBRARY PREPARATION
7.2.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED SAMPLE PROCESSING AND LIBRARY PREPARATION ASSAY KITS IS DRIVING MARKET GROWTH
TABLE 31 SAMPLE PROCESSING & LIBRARY PREPARATION MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 32 NORTH AMERICA: SAMPLE PROCESSING & LIBRARY PREPARATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 33 EUROPE: SAMPLE PROCESSING & LIBRARY PREPARATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 34 APAC: SAMPLE PROCESSING & LIBRARY PREPARATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 SEQUENCING
7.3.1 SANGER SEQUENCING HAS BEEN SUPPLANTED BY NGS DUE TO ITS ADVANTAGES AND RAPIDITY
TABLE 35 SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 36 NORTH AMERICA: SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 37 EUROPE: SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 38 APAC: SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 DATA PROCESSING & ANALYSIS
7.4.1 NEED FOR SKILLED PERSONNEL TO OPERATE DATA PROCESSING AND ANALYTICS TOOLS HAS SLOWED MARKET GROWTH
TABLE 39 DATA PROCESSING & ANALYSIS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 40 NORTH AMERICA: DATA PROCESSING & ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 41 EUROPE: DATA PROCESSING & ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 42 APAC: DATA PROCESSING & ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY (Page No. – 96)
8.1 INTRODUCTION
TABLE 43 METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
8.2 16S RRNA SEQUENCING
8.2.1 16S RRNA SEQUENCING IS A COST-EFFECTIVE TECHNIQUE FOR THE IDENTIFICATION OF BACTERIAL STRAINS
TABLE 44 16S RRNA SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 45 NORTH AMERICA: 16S RRNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 46 EUROPE: 16S RRNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 47 APAC: 16S RRNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 SHOTGUN METAGENOMIC SEQUENCING
8.3.1 SHOTGUN METAGENOMIC SEQUENCING SEGMENT TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
TABLE 48 SHOTGUN METAGENOMIC SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 49 NORTH AMERICA: SHOTGUN METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 50 EUROPE: SHOTGUN METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 51 APAC: SHOTGUN METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY
8.4.1 WGS HELPS GENERATE ACCURATE REFERENCE GENOMES FOR MICROBIAL IDENTIFICATION
TABLE 52 WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 53 NORTH AMERICA: WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 54 EUROPE: WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 55 APAC: WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.5 METATRANSCRIPTOMICS
8.5.1 METATRANSCRIPTOMICS HELPS IN THE UNDERSTANDING OF THE ACTIVE FUNCTIONAL PROFILE OF A MICROBIAL COMMUNITY
TABLE 56 METATRANSCRIPTOMICS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 57 NORTH AMERICA: METATRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 58 EUROPE: METATRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 59 APAC: METATRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
9 METAGENOMIC SEQUENCING MARKET, BY APPLICATION (Page No. – 106)
9.1 INTRODUCTION
TABLE 60 METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.2 DRUG DISCOVERY
9.2.1 DRUG DISCOVERY ACCOUNTS FOR THE LARGEST SHARE OF THE METAGENOMIC SEQUENCING MARKET
TABLE 61 METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY, BY REGION, 2020–2027 (USD MILLION)
TABLE 62 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 63 EUROPE: METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 64 APAC: METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 CLINICAL DIAGNOSTICS
9.3.1 ADVANTAGES OF METAGENOMIC NGS HAVE ENABLED WIDE APPLICATIONS IN DIAGNOSTICS
TABLE 65 METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
TABLE 66 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 67 EUROPE: METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 68 APAC: METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
9.4 SOIL MICROBIOME APPLICATIONS
9.4.1 NORTH AMERICA SHOWS HIGH DEMAND FOR METAGENOMIC SEQUENCING IN SOIL MICROBIOME APPLICATIONS
TABLE 69 METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 70 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 71 EUROPE: METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 72 APAC: METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
9.5 INDUSTRIAL APPLICATIONS
TABLE 73 METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 74 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 75 EUROPE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 76 APAC: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 77 METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
9.5.1 ENERGY
9.5.1.1 Declining fossil fuel reserves and growing energy needs will drive market growth
TABLE 78 METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 79 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 80 EUROPE: METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 81 APAC: METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
9.5.2 BIOREMEDIATION
9.5.2.1 Need to monitor pollutant impact and contamination will provide opportunities for metagenomic sequencing in bioremediation
TABLE 82 METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION, BY REGION, 2020–2027 (USD MILLION)
TABLE 83 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 84 EUROPE: METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 85 APAC: METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION, BY COUNTRY, 2020–2027 (USD MILLION)
9.5.3 OTHER INDUSTRIAL APPLICATIONS
TABLE 86 METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 87 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 88 EUROPE: METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 89 APAC: METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
9.6 ECOLOGICAL & ENVIRONMENTAL APPLICATIONS
9.6.1 METAGENOMIC SEQUENCING CAN HELP IDENTIFY INVASIVE AND ENDANGERED SPECIES
TABLE 90 METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 91 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 92 EUROPE: METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 93 APAC: METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
9.7 VETERINARY APPLICATIONS
9.7.1 DEMAND FOR RAPID AND ACCURATE PATHOGEN DIAGNOSIS IS SUPPORTING THE DEMAND FOR SEQUENCING
TABLE 94 METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 95 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 96 EUROPE: METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 97 APAC: METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
9.8 OTHER APPLICATIONS
TABLE 98 METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 99 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 100 EUROPE: METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 101 APAC: METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
10 METAGENOMIC SEQUENCING MARKET, BY REGION (Page No. – 125)
10.1 INTRODUCTION
TABLE 102 METAGENOMIC SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 26 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET SNAPSHOT
TABLE 103 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 104 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)
TABLE 105 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 106 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 107 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 108 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 Well-established infrastructure and funding sources available for NGS-based small- and medium-sized research projects make the US the largest market in North America
TABLE 109 US: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)
TABLE 110 US: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 111 US: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 112 US: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 113 US: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Increasing government initiatives and workshops to support growth in this market
TABLE 114 CANADA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)
TABLE 115 CANADA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 116 CANADA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 117 CANADA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 118 CANADA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
10.3 EUROPE
TABLE 119 EUROPE: METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 120 EUROPE: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)
TABLE 121 EUROPE: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 122 EUROPE: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 123 EUROPE: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 124 EUROPE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany has witnessed a significant increase in investments in next-generation technologies, making it the largest market in Europe
TABLE 125 GERMANY: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)
TABLE 126 GERMANY: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 127 GERMANY: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 128 GERMANY: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 129 GERMANY: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 Government initiatives to support genomics research drive growth in the metagenomic sequencing market in France
TABLE 130 FRANCE: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)
TABLE 131 FRANCE: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 132 FRANCE: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 133 FRANCE: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 134 FRANCE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
10.3.3 UK
10.3.3.1 Favorable funding scenario for genomics research in the country to support the adoption of NGS
TABLE 135 UK: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)
TABLE 136 UK: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 137 UK: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 138 UK: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 139 UK: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
10.3.4 REST OF EUROPE
TABLE 140 ROE: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)
TABLE 141 ROE: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 142 ROE: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 143 ROE: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 144 ROE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 27 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET SNAPSHOT
TABLE 145 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 146 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)
TABLE 147 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 148 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 149 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 150 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
10.4.1 CHINA
10.4.1.1 Several key market players are focusing on strengthening their presence and offerings in China—a key factor driving market growth
TABLE 151 CHINA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)
TABLE 152 CHINA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 153 CHINA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 154 CHINA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 155 CHINA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Rising use of metagenomic sequencing for various applications to drive market growth in Japan
TABLE 156 JAPAN: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)
TABLE 157 JAPAN: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 158 JAPAN: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 159 JAPAN: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 160 JAPAN: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Increasing adoption of strategies such as collaborations and partnerships by various private and government bodies to drive market growth
TABLE 161 INDIA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)
TABLE 162 INDIA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 163 INDIA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 164 INDIA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 165 INDIA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 166 ROAPAC: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)
TABLE 167 ROAPAC: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 168 ROAPAC: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 169 ROAPAC: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 170 ROAPAC: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
10.4.5 LATIN AMERICA
10.4.5.1 Introduction of low-cost sequencing technologies is expected to drive the market
TABLE 171 LATAM: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)
TABLE 172 LATAM: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 173 LATAM: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 174 LATAM: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 175 LATAM: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
10.4.6 MIDDLE EAST & AFRICA
10.4.6.1 Rising awareness of advanced sequencing technologies is expected to drive market growth in the coming years
TABLE 176 MEA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)
TABLE 177 MEA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 178 MEA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 179 MEA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 180 MEA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. – 170)
11.1 KEY PLAYER STRATEGIES
FIGURE 28 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE METAGENOMIC SEQUENCING MARKET
11.2 MARKET SHARE ANALYSIS
FIGURE 29 METAGENOMIC SEQUENCING MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2020
TABLE 181 METAGENOMIC SEQUENCING MARKET: DEGREE OF COMPETITION
11.3 REVENUE ANALYSIS
FIGURE 30 REVENUE ANALYSIS FOR KEY COMPANIES (2018-2021)
11.4 COMPANY EVALUATION QUADRANT
FIGURE 31 METAGENOMIC SEQUENCING MARKET: COMPANY EVALUATION MATRIX, 2021
11.4.1 STARS
11.4.2 PERVASIVE PLAYERS
11.4.3 EMERGING LEADERS
11.4.4 PARTICIPANTS
11.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS)
FIGURE 32 METAGENOMIC SEQUENCING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS, 2021
11.5.1 PROGRESSIVE COMPANIES
11.5.2 STARTING BLOCKS
11.5.3 DYNAMIC COMPANIES
11.5.4 RESPONSIVE COMPANIES
11.6 COMPETITIVE BENCHMARKING
TABLE 182 COMPANY PRODUCT FOOTPRINT (25 COMPANIES)
TABLE 183 COMPANY REGION FOOTPRINT (25 COMPANIES)
11.7 COMPETITIVE SCENARIO
11.7.1 PRODUCT LAUNCHES
TABLE 184 METAGENOMIC SEQUENCING MARKET: PRODUCT LAUNCHES, JANUARY 2018-FEBRUARY 2022
11.7.2 DEALS
TABLE 185 METAGENOMIC SEQUENCING MARKET: DEALS, JANUARY 2018-FEBRUARY 2022
11.7.3 OTHER DEVELOPMENTS
TABLE 186 METAGENOMIC SEQUENCING MARKET: OTHER DEVELOPMENTS, JANUARY 2018-FEBRUARY 2022
12 COMPANY PROFILES (Page No. – 182)
12.1 MAJOR PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 ILLUMINA, INC.
TABLE 187 ILLUMINA, INC.: BUSINESS OVERVIEW
FIGURE 33 ILLUMINA, INC.: COMPANY SNAPSHOT (2021)
12.1.2 THERMO FISHER SCIENTIFIC, INC.
TABLE 188 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 34 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
12.1.3 QIAGEN N.V.
TABLE 189 QIAGEN N.V.: BUSINESS OVERVIEW
FIGURE 35 QIAGEN N.V.: COMPANY SNAPSHOT (2020)
12.1.4 PERKINELMER, INC.
TABLE 190 PERKINELMER, INC.: BUSINESS OVERVIEW
FIGURE 36 PERKINELMER, INC.: COMPANY SNAPSHOT (2021)
12.1.5 OXFORD NANOPORE TECHNOLOGIES, PLC.
TABLE 191 OXFORD NANOPORE TECHNOLOGIES, PLC.: BUSINESS OVERVIEW
12.1.6 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
TABLE 192 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: BUSINESS OVERVIEW
FIGURE 37 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: COMPANY SNAPSHOT (2020)
12.1.7 BGI GROUP
TABLE 193 BGI GROUP: BUSINESS OVERVIEW
12.1.8 PSOMAGEN, INC.
TABLE 194 PSOMAGEN, INC.: BUSINESS OVERVIEW
12.1.9 EUROFINS SCIENTIFIC
TABLE 195 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 38 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2020)
12.1.10 BROOKS AUTOMATION, INC.
TABLE 196 BROOKS AUTOMATION, INC.: BUSINESS OVERVIEW
FIGURE 39 BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT (2020)
12.1.11 NOVOGENE CO., LTD.
TABLE 197 NOVOGENE CO., LTD.: BUSINESS OVERVIEW
12.1.12 ZYMO RESEARCH CORPORATION
TABLE 198 ZYMO RESEARCH CORPORATION: BUSINESS OVERVIEW
12.1.13 TECAN TRADING AG
TABLE 199 TECAN TRADING AG: BUSINESS OVERVIEW
FIGURE 40 TECAN TRADING AG: COMPANY SNAPSHOT (2020)
12.1.14 INTEGRAGEN SA
TABLE 200 INTEGRAGEN SA: BUSINESS OVERVIEW
FIGURE 41 INTEGRAGEN SA: COMPANY SNAPSHOT (2020)
12.1.15 MICROSYNTH AG
TABLE 201 MICROSYNTH AG: BUSINESS OVERVIEW
12.1.16 DNASTAR, INC.
TABLE 202 DNASTAR: BUSINESS OVERVIEW
12.2 OTHER COMPANIES
12.2.1 COSMOSID, INC.
TABLE 203 COSMOSID, INC.: COMPANY OVERVIEW
12.2.2 GENEXA AG
TABLE 204 GENEXA AG.: COMPANY OVERVIEW
12.2.3 VARIGEN BIOSCIENCES CORPORATION
TABLE 205 VARIGEN BIOSCIENCES: COMPANY OVERVIEW
12.2.4 VERITAS GENETICS
TABLE 206 VERITAS GENETICS: COMPANY OVERVIEW
12.2.5 SINGENE
TABLE 207 SINGENE: COMPANY OVERVIEW
12.2.6 METAGENOMI
TABLE 208 METAGENOMI: COMPANY OVERVIEW
12.2.7 COMPUTOMICS
TABLE 209 COMPUTOMICS: COMPANY OVERVIEW
12.2.8 IDBYDNA, INC.
TABLE 210 IDBYDNA, INC.: COMPANY OVERVIEW
12.2.9 INTACT GENOMICS, INC.
TABLE 211 INTACT GENOMICS, INC. COMPANY OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX (Page No. – 240)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
